Zentalis Pharmaceuticals
ZNTL
$11.06
Share price
0.68%
Change (1 day)
-49.24%
Change (1 year)
Categories
Zentalis Pharmaceuticals (ZNTL) - P/B ratio
P/B ratio as of April 2024 : 1.80
According to Zentalis Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 1.80.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Zentalis Pharmaceuticals - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.45 | -7.44% |
| 2022-12-31 | 2.65 | -74.66% |
| 2021-12-31 | 10.4 | 65.13% |
| 2020-12-31 | 6.33 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6322 | -64.83% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.44 | -19.89% | 🇺🇸 USA |